Studies have shown that most patients are eager and willing to participate in clinical research, but that only a small fraction of them end up enrolling in clinical trials due to various enrollment barriers.
Childhood cancer bill passes the Senate
The U.S. Senate just passed the STAR Act, a bipartisan bill that lays the groundwork for new breakthroughs in researching and treating childhood cancer.
The STAR Act provides the opportunity to:
- Increase funding for childhood cancer research
- Improve data collection so pediatric oncologists can better learn from one another
- Expand research on the long-term effects of childhood cancer treatments
More than 10,000 children will be diagnosed with childhood cancer this year, and far too many will face grueling medical treatments and a lifetime of potential chronic health conditions.
The STAR Act addresses these issues by increasing research for more effective treatments for children fighting cancer and studying the long-term effects of this disease on childhood cancer survivors.
The bill now must go to the House of Representatives. Send a message to your Representative and ask them to pass the STAR Act so the bill can become a law.